Effect of biphasic insulin aspart 30/70 (BIAsp30) in combination with metformin on glycaemic control in subjects with type 2 diabetes not optimally controlled on oral antidiabetic agents

被引：0

作者：

Naiker, P.

Makan, H. A.

Omar, M. A. K.

Kedijang, T.

Kong, L. L. L.

机构：

[1] St Augustines Hosp, Durban, South Africa

[2] Novo Nordisk, Johannesburg, South Africa

[3] Novo Nordisk, Singapore, Singapore

来源：

DIABETOLOGIA | 2006年 / 49卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

0983

引用

页码：599 / 600

页数：2

共 50 条

[21] Serum 1,5-anhydroglucitol as a marker of glycemic control in subjects receiving twice-daily biphasic insulin aspart 70/30 (BIAsp 70/30) vs. once-daily insulin glargine in patients with type 2 DM on oral antidiabetic agents
Moses, A
Raskin, P
Hu, P
Allen, E
DIABETES, 2005, 54 : A96 - A96
[22] Patients with Type 2 diabetes mellitus have lower rates of nocturnal hypoglycaemia on biphasic insulin aspart (BIAsp30) than on biphasic human insulin-30 (BHI30): data from the REACH study
McNally, PG
Nelson, G
Fitch, M
DIABETOLOGIA, 2004, 47 : A327 - A327
[23] Use of a New Basal Insulin with a Bolus Boost (IDegAsp) in Type 2 Diabetes: Comparison with Biphasic Insulin Aspart 30 (BIAsp 30)
Vaag, Allan
Leiter, Lawrence A.
Franek, Edward
Weng, Jianping
Damci, Taner
Munoz Torres, Manuel
Donnet, Jean-Paul
Endahl, Lars
Skjoth, Trine V.
Niskanen, Leo
DIABETES, 2011, 60 : A313 - A313
[24] Efficacy and safety of biphasic insulin aspart 70/30 versus exenatide in subjects with type 2 diabetes failing to achieve glycemic control with metformin and a sulfonylurea
Bergenstal, Richard
Lewin, Andrew
Bailey, Timothy
Chang, Denise
Gylvin, Titus
Roberts, Victor
CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (01) : 65 - 75
[25] Thrice-daily injections of biphasic insulin aspart 30 (NovoMix® 70/30) improves glycaemic control in patients with type 1 diabetes
Chen, JW
Lauritzen, T
Bojesen, A
Christiansen, J
DIABETOLOGIA, 2005, 48 : A330 - A330
[26] Treatment with biphasic insulin aspart 30 improves glycaemic control in patients with Type 2 diabetes inadequately controlled with oral antidiabetic drugs: results from China cohort in the PRESENT study
Gao, Yan
DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 79 : S64 - S65
[27] Intensification to biphasic insulin aspart 30/70 (BIAsp 30, NovoMix® 30) can improve glycaemic control in patients treated with basal insulins: a subgroup analysis of the IMPROVE™ observational study
Gumprecht, J.
Benroubi, M.
Borzi, V.
Kawamori, R.
Shaban, J.
Shah, S.
Shestakova, M.
Wenying, Y.
Ligthelm, R.
Valensi, P.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2009, 63 (06) : 966 - 972
[28] A randomized, open-label, multicentre, parallel-controlled study comparing the efficacy and safety of biphasic insulin aspart 30 plus metformin with biphasic insulin aspart 30 monotherapy for type 2 diabetes patients inadequately controlled with oral antidiabetic drugs: The merit study
Guo, Lixin
Chen, Li
Chang, Baocheng
Yang, Liyong
Liu, Yu
Feng, Bo
DIABETES OBESITY & METABOLISM, 2018, 20 (12): : 2740 - 2747
[29] Improved glycaemic control in over 11,000 elderly patients from the IMPROVE™ Study of biphasic insulin aspart 30/70 (BIAsp 30) in eight countries
Borzi, V.
Shah, S.
Knudsen, V. K.
DIABETOLOGIA, 2009, 52 : S348 - S348
[30] Thrice-daily biphasic insulin aspart 30 may be another therapeutic option for Chinese patients with type 2 diabetes inadequately controlled with oral antidiabetic agents
YANG Wenying JI Qiuhe ZHU Dalong YANG Jinkui CHEN Lulu LIU Zhimin YU Demin YAN Li Department of EndocrinologyChinaJapan Friendship HospitalBeijing ChinaDepartment of EndocrinologyXijing Hospital Affiliated to th Military Medical UniversityXianShaanxi ChinaDepartment of EndocrinologyNanjing Drum Tower HospitalNanjingJiangsu ChinaDepartment of EndocrinologyBeijing Tongren HospitalBeijing ChinaDepartment of EndocrinologyWuhan Union HospitalWuhanHubei ChinaDepartment of EndocrinologyShanghai Changzheng HospitalShanghai ChinaDepartment of EndocrinologyMetabolic Disease Hospital Affiliated to Tianjin Medical UniversityTianjin ChinaDepartment of EndocrinologySun Yatsen Memorial Hospital Affiliated to Zhongshan UniversityGuangzhouGuangdong China
中华医学杂志（英文版）, 2009, (14) : 1704 - 1708

← 1 2 3 4 5 →